Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) Royalty Revenue (Deprecated 2018-01-31)

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Royalty Revenue (Deprecated 2018-01-31)

LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Royalty Revenue (Deprecated 2018-01-31) of $20.82 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.

Discontinued › Income Statement › Other Income

us-gaap:RoyaltyRevenue · last filed 2018-05-09

  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $20.82M, a 14.07% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $28.31M, a 44.59% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $21.93M, a 39.71% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $14.21M, a 45.69% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for fiscal 2017 was $88.69M, a 49.24% increase from fiscal 2016.
  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for fiscal 2016 was $59.42M, a 55.58% increase from fiscal 2015.
  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for fiscal 2015 was $38.19M, a 27.34% increase from fiscal 2014.
  • LIGAND PHARMACEUTICALS INCORPORATED royalty revenue (deprecated 2018-01-31) for fiscal 2014 was $29.99M, a 27.18% increase from fiscal 2013.
Period endRoyalty Revenue (Deprecated 2018-01-31) 3 monthRoyalty Revenue (Deprecated 2018-01-31) 6 monthRoyalty Revenue (Deprecated 2018-01-31) 9 monthRoyalty Revenue (Deprecated 2018-01-31) 12 monthRoyalty Revenue (Deprecated 2018-01-31) 12 month as first filed
2018-03-31$20.82M
10-Q · filed 2018-05-09
$49.13M
derived: sum of 2 quarters · filed 2018-05-09
$71.06M
derived: sum of 3 quarters · filed 2018-05-09
$85.28M
derived: sum of 4 quarters · filed 2018-05-09
2017-12-31$28.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$50.24M
derived: sum of 2 quarters · filed 2018-03-01
$64.45M
derived: sum of 3 quarters · filed 2018-03-01
$88.69M
10-K · filed 2018-03-01
2017-09-30$21.93M
10-Q · filed 2017-11-09
$36.14M
derived: sum of 2 quarters · filed 2017-11-09
$60.37M
10-Q · filed 2017-11-09
$79.95M
derived: sum of 4 quarters · filed 2018-05-09
2017-06-30$14.21M
10-Q · filed 2017-08-09
$38.44M
10-Q · filed 2017-08-09
$58.02M
derived: sum of 3 quarters · filed 2018-05-09
$73.72M
derived: sum of 4 quarters · filed 2018-05-09
2017-03-31$24.23M
10-Q · filed 2018-05-09
$43.81M
derived: sum of 2 quarters · filed 2018-05-09
$59.51M
derived: sum of 3 quarters · filed 2018-05-09
$69.26M
derived: sum of 4 quarters · filed 2018-05-09
2016-12-31$19.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$35.28M
derived: sum of 2 quarters · filed 2018-03-01
$45.03M
derived: sum of 3 quarters · filed 2018-03-01
$59.42M
10-K · filed 2018-03-01
2016-09-30$15.70M
10-Q · filed 2017-11-09
$25.45M
derived: sum of 2 quarters · filed 2017-11-09
$39.84M
10-Q · filed 2017-11-09
$51.39M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$9.75M
10-Q · filed 2017-08-09
$24.14M
10-Q · filed 2017-08-09
$35.69M
derived: sum of 3 quarters · filed 2018-03-01
$45.45M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$14.39M
10-Q · filed 2017-05-09
$25.94M
derived: sum of 2 quarters · filed 2018-03-01
$35.69M
derived: sum of 3 quarters · filed 2018-03-01
$42.30M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$11.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$21.30M
derived: sum of 2 quarters · filed 2018-03-01
$27.91M
derived: sum of 3 quarters · filed 2018-03-01
$38.19M
10-K · filed 2018-03-01
2015-09-30$9.76M
10-Q · filed 2016-11-14
$16.36M
derived: sum of 2 quarters · filed 2016-11-14
$26.65M
10-Q · filed 2016-11-14
$36.07M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$6.61M
10-Q · filed 2016-11-14
$16.89M
10-Q · filed 2016-11-14
$26.31M
derived: sum of 3 quarters · filed 2017-02-28
$33.80M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$10.29M
10-Q · filed 2016-11-14
$19.71M
derived: sum of 2 quarters · filed 2017-02-28
$27.19M
derived: sum of 3 quarters · filed 2017-02-28
$32.43M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$9.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$16.90M
derived: sum of 2 quarters · filed 2017-02-28
$22.14M
derived: sum of 3 quarters · filed 2017-02-28
$29.99M
10-K · filed 2017-02-28
$23.58M
10-K · filed 2014-12-01
2014-09-30$7.48M
10-Q · filed 2015-11-09
$12.72M
derived: sum of 2 quarters · filed 2015-11-09
$20.57M
10-Q · filed 2015-11-09
$27.69M
derived: sum of 4 quarters · filed 2016-11-14
2014-06-30$5.24M
10-Q · filed 2015-08-05
$13.09M
10-Q · filed 2015-08-05
$20.21M
derived: sum of 3 quarters · filed 2016-11-14
$25.93M
derived: sum of 4 quarters · filed 2016-11-14
2014-03-31$7.85M
10-Q · filed 2015-05-11
$14.97M
derived: sum of 2 quarters · filed 2016-11-14
$20.69M
derived: sum of 3 quarters · filed 2016-11-14
$25.61M
derived: sum of 4 quarters · filed 2016-11-14
2013-12-31$7.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14
$12.84M
derived: sum of 2 quarters · filed 2016-11-14
$17.76M
derived: sum of 3 quarters · filed 2016-11-14
$23.58M
10-K · filed 2016-11-14
2013-09-30$5.72M
10-Q · filed 2014-10-31
$10.64M
derived: sum of 2 quarters · filed 2014-10-31
$16.47M
10-Q · filed 2014-10-31
$21.28M
derived: sum of 4 quarters · filed 2015-02-23
2013-06-30$4.92M
10-Q · filed 2014-08-05
$10.74M
10-Q · filed 2014-08-05
$15.56M
derived: sum of 3 quarters · filed 2015-02-23
$18.77M
derived: sum of 4 quarters · filed 2015-02-23
2013-03-31$5.83M
10-Q · filed 2014-05-07
$10.64M
derived: sum of 2 quarters · filed 2015-02-23
$13.86M
derived: sum of 3 quarters · filed 2015-02-23
$16.84M
derived: sum of 4 quarters · filed 2015-02-23
2012-12-31$4.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23
$8.03M
derived: sum of 2 quarters · filed 2015-02-23
$11.01M
derived: sum of 3 quarters · filed 2015-02-23
$14.07M
10-K · filed 2015-02-23
2012-09-30$3.21M
10-Q · filed 2013-11-08
$6.20M
derived: sum of 2 quarters · filed 2013-11-08
$9.26M
10-Q · filed 2013-11-08
$11.87M
derived: sum of 4 quarters · filed 2014-12-12
2012-06-30$2.98M
10-Q · filed 2013-08-01
$6.04M
10-Q · filed 2013-08-01
$8.66M
derived: sum of 3 quarters · filed 2014-12-12
$11.09M
derived: sum of 4 quarters · filed 2014-12-12
2012-03-31$3.06M
10-Q · filed 2013-05-08
$5.68M
derived: sum of 2 quarters · filed 2014-12-12
$8.11M
derived: sum of 3 quarters · filed 2014-12-12
$10.28M
derived: sum of 4 quarters · filed 2014-12-12
2011-12-31$2.62M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12
$5.05M
derived: sum of 2 quarters · filed 2014-12-12
$7.22M
derived: sum of 3 quarters · filed 2014-12-12
$9.21M
10-K/A · filed 2014-12-12
2011-09-30$2.43M
10-Q · filed 2012-11-14
$4.60M
derived: sum of 2 quarters · filed 2012-11-14
$6.60M
10-Q · filed 2012-11-14
$8.54M
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30$2.17M
10-Q/A · filed 2012-11-14
$4.17M
10-Q/A · filed 2012-11-14
$6.11M
derived: sum of 3 quarters · filed 2013-03-14
$7.88M
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31$1.99M
10-Q/A · filed 2012-11-14
$3.94M
derived: sum of 2 quarters · filed 2013-03-14
$5.71M
derived: sum of 3 quarters · filed 2013-03-14
$7.31M
derived: sum of 4 quarters · filed 2013-03-14
2010-12-31$1.94M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-14
$3.72M
derived: sum of 2 quarters · filed 2013-03-14
$5.32M
derived: sum of 3 quarters · filed 2013-03-14
$7.28M
10-K · filed 2013-03-14
2010-09-30$1.77M
10-Q/A · filed 2012-02-10
$3.38M
derived: sum of 2 quarters · filed 2012-02-10
$5.34M
10-Q/A · filed 2012-02-10
2010-06-30$1.60M
10-Q/A · filed 2012-02-10
$3.56M
10-Q/A · filed 2012-02-10
2009-12-31$8.33M
10-K/A · filed 2012-11-14